title: Dreamboat sinks prospects for fast approval of inhaled insulin.
authors.forename: Jim
authors.initials: J
authors.lastname: Kling
mesh_terms: D004345:Drug Industry / Q000639:trends*; D058995:Dry Powder Inhalers / Q000295:instrumentation* / Q000379:methods*; D004867:Equipment Design; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000009:adverse effects; D007328:Insulin / Q000008:administration & dosage* / Q000009:adverse effects; D011358:Product Surveillance, Postmarketing; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D007004:Hypoglycemic Agents; D007328:Insulin